Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 133

1.

Changes in liver stiffness after ART initiation in HIV-infected Nigerian adults with and without chronic HBV.

Grant JL, Agaba P, Ugoagwu P, Muazu A, Okpokwu J, Akpa S, Machenry S, Imade G, Agbaji O, Thio CL, Murphy R, Hawkins C.

J Antimicrob Chemother. 2019 Jul 1;74(7):2003-2008. doi: 10.1093/jac/dkz145.

PMID:
31225612
2.

CCR5AS lncRNA variation differentially regulates CCR5, influencing HIV disease outcome.

Kulkarni S, Lied A, Kulkarni V, Rucevic M, Martin MP, Walker-Sperling V, Anderson SK, Ewy R, Singh S, Nguyen H, McLaren PJ, Viard M, Naranbhai V, Zou C, Lin Z, Gatanaga H, Oka S, Takiguchi M, Thio CL, Margolick J, Kirk GD, Goedert JJ, Hoots WK, Deeks SG, Haas DW, Michael N, Walker B, Le Gall S, Chowdhury FZ, Yu XG, Carrington M.

Nat Immunol. 2019 Jul;20(7):824-834. doi: 10.1038/s41590-019-0406-1. Epub 2019 Jun 17.

PMID:
31209403
3.

Reply to Soriano Gómez-Gallego and Corral.

Patel EU, Thio CL, Boon D, Thomas DL, Tobian AAR.

Clin Infect Dis. 2019 Apr 3. pii: ciz274. doi: 10.1093/cid/ciz274. [Epub ahead of print] No abstract available.

PMID:
30943282
4.
5.

Toll-like receptor 9-dependent interferon production prevents group 2 innate lymphoid cell-driven airway hyperreactivity.

Thio CL, Lai AC, Chi PY, Webster G, Chang YJ.

J Allergy Clin Immunol. 2019 Mar 23. pii: S0091-6749(19)30405-1. doi: 10.1016/j.jaci.2019.03.008. [Epub ahead of print]

PMID:
30914379
6.

Hepatitis B virus coinfection is associated with high early mortality in HIV-infected Tanzanians on antiretroviral therapy.

Christian B, Fabian E, Macha I, Mpangala S, Thio CL, Ulenga N, Mugusi F, Ammerman LR, Fawzi W, Green R, Murphy R, Hawkins C.

AIDS. 2019 Mar 1;33(3):465-473. doi: 10.1097/QAD.0000000000002073.

PMID:
30702515
7.

The effects of hepatitis C treatment eligibility criteria on all-cause mortality among people with HIV.

Breskin A, Westreich D, Hurt CB, Cole SR, Hudgens MG, Seaberg EC, Thio CL, Tien PC, Adimora AA.

Clin Infect Dis. 2019 Jan 7. doi: 10.1093/cid/ciz008. [Epub ahead of print]

PMID:
30615096
8.

Prevalence of Hepatitis B and Hepatitis D Virus Infections in the United States, 2011-2016.

Patel EU, Thio CL, Boon D, Thomas DL, Tobian AAR.

Clin Infect Dis. 2019 Jan 3. doi: 10.1093/cid/ciz001. [Epub ahead of print]

PMID:
30605508
9.

Multi-Ancestry Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus.

Vergara C, Thio CL, Johnson E, Kral AH, O'Brien TR, Goedert JJ, Mangia A, Piazzolla V, Mehta SH, Kirk GD, Kim AY, Lauer GM, Chung RT, Cox AL, Peters MG, Khakoo SI, Alric L, Cramp ME, Donfield SM, Edlin BR, Busch MP, Alexander G, Rosen HR, Murphy EL, Latanich R, Wojcik GL, Taub MA, Valencia A, Thomas DL, Duggal P.

Gastroenterology. 2019 Apr;156(5):1496-1507.e7. doi: 10.1053/j.gastro.2018.12.014. Epub 2018 Dec 26.

PMID:
30593799
10.

CCR5 deficiency enhances hepatic innate immune cell recruitment and inflammation in a murine model of acute hepatitis B infection.

Stevens KE, Thio CL, Osburn WO.

Immunol Cell Biol. 2019 Mar;97(3):317-325. doi: 10.1111/imcb.12221. Epub 2019 Jan 24.

PMID:
30536991
11.

Inhibitory killer cell immunoglobulin-like receptors strengthen CD8+ T cell-mediated control of HIV-1, HCV, and HTLV-1.

Boelen L, Debebe B, Silveira M, Salam A, Makinde J, Roberts CH, Wang ECY, Frater J, Gilmour J, Twigger K, Ladell K, Miners KL, Jayaraman J, Traherne JA, Price DA, Qi Y, Martin MP, Macallan DC, Thio CL, Astemborski J, Kirk G, Donfield SM, Buchbinder S, Khakoo SI, Goedert JJ, Trowsdale J, Carrington M, Kollnberger S, Asquith B.

Sci Immunol. 2018 Nov 9;3(29). pii: eaao2892. doi: 10.1126/sciimmunol.aao2892.

12.

The Effects of Hepatitis C Infection and Treatment on All-cause Mortality Among People Living With Human Immunodeficiency Virus.

Breskin A, Westreich D, Cole SR, Hudgens MG, Hurt CB, Seaberg EC, Thio CL, Tien PC, Adimora AA.

Clin Infect Dis. 2019 Mar 19;68(7):1152-1159. doi: 10.1093/cid/ciy588. Erratum in: Clin Infect Dis. 2019 Mar 11;:.

PMID:
30321289
13.

Aspartate aminotransferase-to-platelet ratio index increases significantly 3 years prior to liver-related death in HIV-hepatitis-coinfected men.

Price JC, Seaberg EC, Stosor V, Witt MD, Lellock CD, Thio CL.

AIDS. 2018 Nov 13;32(17):2636-2638. doi: 10.1097/QAD.0000000000001977.

PMID:
30096072
14.

Direct-Acting Antivirals and Hepatitis C: The Ethics of Price and Rationing by Genotype.

Walker A, Boyce A, Geller G, Thio CL, Kahn JP.

Clin Infect Dis. 2018 Aug 31;67(6):983-984. doi: 10.1093/cid/ciy239. No abstract available.

PMID:
29617735
15.

Regulation of type 2 innate lymphoid cell-dependent airway hyperreactivity by butyrate.

Thio CL, Chi PY, Lai AC, Chang YJ.

J Allergy Clin Immunol. 2018 Dec;142(6):1867-1883.e12. doi: 10.1016/j.jaci.2018.02.032. Epub 2018 Mar 6.

PMID:
29522844
16.

Knowledge regarding hepatitis B mother-to-child transmission among healthcare workers in South China.

Chen Y, Xie C, Zhang Y, Li Y, Ehrhardt S, Thio CL, Nelson KE, Chen Y, Lin CS.

J Viral Hepat. 2018 May;25(5):561-570. doi: 10.1111/jvh.12839. Epub 2018 Jan 24.

PMID:
29194878
17.

Fine-mapping of genetic loci driving spontaneous clearance of hepatitis C virus infection.

Huang H, Duggal P, Thio CL, Latanich R, Goedert JJ, Mangia A, Cox AL, Kirk GD, Mehta S, Aneja J, Alric L, Donfield SM, Cramp ME, Khakoo SI, Tobler LH, Busch M, Alexander GJ, Rosen HR, Edlin BR, Segal FP, Lauer GM, Thomas DL, Daly MJ, Chung RT, Kim AY.

Sci Rep. 2017 Nov 20;7(1):15843. doi: 10.1038/s41598-017-16011-2.

18.

Brief Report: HIV/HBV Coinfection is a Significant Risk Factor for Liver Fibrosis in Tanzanian HIV-Infected Adults.

Hawkins C, Christian B, Fabian E, Macha I, Gawile C, Mpangala S, Ulenga N, Thio CL, Ammerman LR, Mugusi F, Fawzi W, Green R, Murphy R.

J Acquir Immune Defic Syndr. 2017 Nov 1;76(3):298-302. doi: 10.1097/QAI.0000000000001491.

19.

The Association of Inflammatory Markers With Nonalcoholic Fatty Liver Disease Differs by Human Immunodeficiency Virus Serostatus.

Price JC, Wang R, Seaberg EC, Budoff MJ, Kingsley LA, Palella FJ, Witt MD, Post WS, Thio CL.

Open Forum Infect Dis. 2017 Jul 23;4(3):ofx153. doi: 10.1093/ofid/ofx153. eCollection 2017 Summer.

20.

Comparison of Hepatitis B Virus Infection in HIV-Infected and HIV-Uninfected Participants Enrolled in a Multinational Clinical Trial: HPTN 052.

Greer AE, Ou SS, Wilson E, Piwowar-Manning E, Forman MS, McCauley M, Gamble T, Ruangyuttikarn C, Hosseinipour MC, Kumarasamy N, Nyirenda M, Grinsztejn B, Pilotto JH, Kosashunhanan N, Gonçalves de Melo M, Makhema J, Akelo V, Panchia R, Badal-Faesen S, Chen YQ, Cohen MS, Eshleman SH, Thio CL, Valsamakis A.

J Acquir Immune Defic Syndr. 2017 Dec 1;76(4):388-393. doi: 10.1097/QAI.0000000000001511.

21.

Knowledge of and attitudes towards hepatitis B and its transmission from mother to child among pregnant women in Guangdong Province, China.

Han Z, Yin Y, Zhang Y, Ehrhardt S, Thio CL, Nelson KE, Bai X, Hou H.

PLoS One. 2017 Jun 2;12(6):e0178671. doi: 10.1371/journal.pone.0178671. eCollection 2017.

22.

Elevated pre-treatment IL-18 level is associated with HBeAg seroconversion in HIV-HBV coinfection.

Li Y, Xie J, Wang H, Han Y, Wang N, Thio CL, Li T.

Antivir Ther. 2017;22(6):523-527. doi: 10.3851/IMP3136. Epub 2017 Feb 14.

23.

Protein Palmitoylation by ZDHHC13 Protects Skin against Microbial-Driven Dermatitis.

Chen LY, Yang-Yen HF, Tsai CC, Thio CL, Chuang HL, Yang LT, Shen LF, Song IW, Liu KM, Huang YT, Liu FT, Chang YJ, Chen YT, Yen JJY.

J Invest Dermatol. 2017 Apr;137(4):894-904. doi: 10.1016/j.jid.2016.12.011. Epub 2016 Dec 23.

24.

Favorable Socioeconomic Status and Recreational Polydrug Use Are Linked With Sexual Hepatitis C Virus Transmission Among Human Immunodeficiency Virus-Infected Men Who Have Sex With Men.

Chen YC, Wiberg KJ, Hsieh YH, Bansal A, Bolzan P, Guy JA, Maina EN, Cox AL, Thio CL.

Open Forum Infect Dis. 2016 Jun 29;3(3):ofw137. eCollection 2016 Sep.

25.

Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy Eras.

Klein MB, Althoff KN, Jing Y, Lau B, Kitahata M, Lo Re V 3rd, Kirk GD, Hull M, Kim HN, Sebastiani G, Moodie EE, Silverberg MJ, Sterling TR, Thorne JE, Cescon A, Napravnik S, Eron J, Gill MJ, Justice A, Peters MG, Goedert JJ, Mayor A, Thio CL, Cachay ER, Moore R; North American AIDS Cohort Collaboration on Research and Design of IeDEA; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA.

Clin Infect Dis. 2016 Nov 1;63(9):1160-1167. Epub 2016 Aug 9.

26.

Prevalence of hepatitis B and C viruses in HIV-positive patients in China: a cross-sectional study.

Xie J, Han Y, Qiu Z, Li Y, Li Y, Song X, Wang H, Thio CL, Li T.

J Int AIDS Soc. 2016 Mar 14;19(1):20659. doi: 10.7448/IAS.19.1.20659. eCollection 2016.

27.

Brief Report: Highly Active Antiretroviral Therapy Mitigates Liver Disease in HIV Infection.

Price JC, Seaberg EC, Phair JP, Witt MD, Koletar SL, Thio CL.

J Acquir Immune Defic Syndr. 2016 Jul 1;72(3):319-23. doi: 10.1097/QAI.0000000000000981.

28.

Combination Antiretroviral Therapy Is Associated With Reduction in Liver Fibrosis Scores in HIV-1-Infected Subjects.

Li Y, Xie J, Han Y, Wang H, Lv W, Guo F, Qiu Z, Li Y, Du S, Song X, Zhu T, Thio CL, Li T.

Medicine (Baltimore). 2016 Feb;95(5):e2660. doi: 10.1097/MD.0000000000002660.

29.

Lamivudine Monotherapy-Based cART Is Efficacious for HBV Treatment in HIV/HBV Coinfection When Baseline HBV DNA <20,000 IU/mL.

Li Y, Xie J, Han Y, Wang H, Zhu T, Wang N, Lv W, Guo F, Qiu Z, Li Y, Du S, Song X, Thio CL, Li T.

J Acquir Immune Defic Syndr. 2016 May 1;72(1):39-45. doi: 10.1097/QAI.0000000000000927.

30.

Incident Hepatitis B Virus Infection in HIV-Infected and HIV-Uninfected Men Who Have Sex With Men From Pre-HAART to HAART Periods: A Cohort Study.

Falade-Nwulia O, Seaberg EC, Snider AE, Rinaldo CR, Phair J, Witt MD, Thio CL.

Ann Intern Med. 2015 Nov 3;163(9):673-80. doi: 10.7326/M15-0547. Epub 2015 Oct 13.

31.

A Cross-sectional Study of the Association Between Chronic Hepatitis C Virus Infection and Subclinical Coronary Atherosclerosis Among Participants in the Multicenter AIDS Cohort Study.

McKibben RA, Haberlen SA, Post WS, Brown TT, Budoff M, Witt MD, Kingsley LA, Palella FJ Jr, Thio CL, Seaberg EC.

J Infect Dis. 2016 Jan 15;213(2):257-65. doi: 10.1093/infdis/jiv396. Epub 2015 Jul 27.

32.

Spontaneous Clearance of the Hepatitis C Virus Among Men Who Have Sex With Men.

Seaberg EC, Witt MD, Jacobson LP, Detels R, Rinaldo CR, Margolick JB, Young S, Phair JP, Thio CL.

Clin Infect Dis. 2015 Nov 1;61(9):1381-8. doi: 10.1093/cid/civ562. Epub 2015 Jul 14.

33.

Global elimination of mother-to-child transmission of hepatitis B: revisiting the current strategy.

Thio CL, Guo N, Xie C, Nelson KE, Ehrhardt S.

Lancet Infect Dis. 2015 Aug;15(8):981-5. doi: 10.1016/S1473-3099(15)00158-9. Epub 2015 Jul 2.

PMID:
26145195
34.

Polymorphisms in melanoma differentiation-associated gene 5 are not associated with clearance of hepatitis C virus in a European American population.

Vergara C, Thio CL, Thomas D, Duggal P.

Hepatology. 2016 Mar;63(3):1061-2. doi: 10.1002/hep.27954. Epub 2015 Jul 28. No abstract available.

35.

Differential Analysis of the Secretome of WRL68 Cells Infected with the Chikungunya Virus.

Thio CL, Yusof R, Ashrafzadeh A, Bahari S, Abdul-Rahman PS, Karsani SA.

PLoS One. 2015 Jun 17;10(6):e0129033. doi: 10.1371/journal.pone.0129033. eCollection 2015.

36.

Editorial Commentary: Another Call to Cure Hepatitis B.

Balagopal A, Thio CL.

Clin Infect Dis. 2015 Oct 15;61(8):1307-9. doi: 10.1093/cid/civ475. Epub 2015 Jun 16. No abstract available.

37.

Comparison of HBV-active HAART regimens in an HIV-HBV multinational cohort: outcomes through 144 weeks.

Thio CL, Smeaton L, Hollabaugh K, Saulynas M, Hwang H, Saravanan S, Kulkarni S, Hakim J, Nyirenda M, Iqbal HS, Lalloo UG, Campbell TB, Lockman S, Currier JS.

AIDS. 2015 Jun 19;29(10):1173-82. doi: 10.1097/QAD.0000000000000686.

38.

Genomics and infectious disease: a call to identify the ethical, legal and social implications for public health and clinical practice.

Geller G, Dvoskin R, Thio CL, Duggal P, Lewis MH, Bailey TC, Sutherland A, Salmon DA, Kahn JP.

Genome Med. 2014 Nov 18;6(11):106. doi: 10.1186/s13073-014-0106-2. eCollection 2014.

39.

Breastfeeding while taking lamivudine or tenofovir disoproxil fumarate: a review of the evidence.

Ehrhardt S, Xie C, Guo N, Nelson K, Thio CL.

Clin Infect Dis. 2015 Jan 15;60(2):275-8. doi: 10.1093/cid/ciu798. Epub 2014 Oct 13. Review.

PMID:
25313254
40.

Differences in hepatitis C virus prevalence and clearance by mode of acquisition among men who have sex with men.

Seaberg EC, Witt MD, Jacobson LP, Detels R, Rinaldo CR, Young S, Phair JP, Thio CL.

J Viral Hepat. 2014 Oct;21(10):696-705. doi: 10.1111/jvh.12198. Epub 2013 Nov 7.

41.

A closer look at hepatitis C clearance in HIV controllers.

Seaberg EC, Thio CL.

AIDS. 2014 May 15;28(8):1242-3. doi: 10.1097/QAD.0000000000000207. No abstract available.

PMID:
25028915
42.

HIV outcomes in Hepatitis B virus coinfected individuals on HAART.

Chun HM, Mesner O, Thio CL, Bebu I, Macalino G, Agan BK, Bradley WP, Malia J, Peel SA, Jagodzinski LL, Weintrob AC, Ganesan A, Bavaro M, Maguire JD, Landrum ML; Infectious Disease Clinical Research Program HIV Working Group.

J Acquir Immune Defic Syndr. 2014 Jun 1;66(2):197-205. doi: 10.1097/QAI.0000000000000142.

43.

Risk factors for fatty liver in the Multicenter AIDS Cohort Study.

Price JC, Seaberg EC, Latanich R, Budoff MJ, Kingsley LA, Palella FJ Jr, Witt MD, Post WS, Thio CL.

Am J Gastroenterol. 2014 May;109(5):695-704. doi: 10.1038/ajg.2014.32. Epub 2014 Mar 18.

44.

Admixture analysis of spontaneous hepatitis C virus clearance in individuals of African descent.

Wojcik GL, Thio CL, Kao WH, Latanich R, Goedert JJ, Mehta SH, Kirk GD, Peters MG, Cox AL, Kim AY, Chung RT, Thomas DL, Duggal P.

Genes Immun. 2014 Apr;15(4):241-6. doi: 10.1038/gene.2014.11. Epub 2014 Mar 13.

45.

Factors associated with delayed hepatitis B viral suppression on tenofovir among patients coinfected with HBV-HIV in the CNICS cohort.

Kim HN, Rodriguez CV, Van Rompaey S, Eron JJ, Thio CL, Crane HM, Overton ET, Saag MS, Martin J, Geng E, Mugavero M, Rodriguez B, Mathews WC, Boswell S, Moore R, Kitahata MM; Centers for AIDS Research Network of Integrated Clinical Systems.

J Acquir Immune Defic Syndr. 2014 May 1;66(1):96-101. doi: 10.1097/QAI.0000000000000126.

46.

Reply to Bradshaw and Danta.

Witt MD, Seaberg EC, Thio CL.

Clin Infect Dis. 2014 Jan;58(1):137. doi: 10.1093/cid/cit606. Epub 2013 Sep 17. No abstract available.

47.

Assessment of liver fibrosis by transient elastography in patients with HIV and hepatitis B virus coinfection in Nigeria.

Hawkins C, Agbaji O, Ugoagwu P, Thio CL, Auwal MM, Ani C, Okafo C, Wallender E, Murphy RL.

Clin Infect Dis. 2013 Dec;57(12):e189-92. doi: 10.1093/cid/cit564. Epub 2013 Sep 6. No abstract available.

48.

Variants in HAVCR1 gene region contribute to hepatitis C persistence in African Americans.

Wojcik G, Latanich R, Mosbruger T, Astemborski J, Kirk GD, Mehta SH, Goedert JJ, Kim AY, Seaberg EC, Busch M, Thomas DL, Duggal P, Thio CL.

J Infect Dis. 2014 Feb 1;209(3):355-9. doi: 10.1093/infdis/jit444. Epub 2013 Aug 20.

49.

Reply to Tsai et al.

Chun HM, Thio CL, Agan BK, Landrum ML; Infectious Disease Clinical Research Program HIV Working Group.

J Infect Dis. 2013 Oct 1;208(7):1186. doi: 10.1093/infdis/jit300. Epub 2013 Jul 9. No abstract available.

50.

Relation of HLA class I and II supertypes with spontaneous clearance of hepatitis C virus.

Kuniholm MH, Anastos K, Kovacs A, Gao X, Marti D, Sette A, Greenblatt RM, Peters M, Cohen MH, Minkoff H, Gange SJ, Thio CL, Young MA, Xue X, Carrington M, Strickler HD.

Genes Immun. 2013 Jul-Aug;14(5):330-5. doi: 10.1038/gene.2013.25. Epub 2013 May 2.

Supplemental Content

Support Center